Director of Drug Safety
Dr. Rai joined OncoC4 as the Director of Drug Safety in early 2022. He is a medical doctor who combines his unique skills as a physician, clinician, drug safety expert, data analyst and educator in his work. He has a wealth of experience in clinical medicine, drug safety and surveillance, clinical research and development, data mining and adult education. He has held positions of increasing responsibility at National Institutes of Health (NIH) and in the pharmaceutical industry working in the areas of clinical research, drug safety and pharmacovigilance. Before joining OncoC4, Dr. Rai was the drug safety and pharmacovigilant consultant for FibroGen, and a lead safety physician for Sarah Cannon Research Institute prior to that.